Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Summary, in English

In rheumatoid arthritis (RA), predictive biomarkers for subsequent radiographic progression (RP) could improve therapeutic choices for individual patients. We previously showed that the multibiomarker disease activity (MBDA) score in patients with newly diagnosed RA identified patients at risk for RP. We evaluated the MBDA score at multiple time-points as a predictor of RP during 2 years of follow-up.

• Author: Karen Hambardzumyan; Rebecca J Bolce; Saedis Saevarsdottir; Kristina Forslind; JOHAN KARLSSON WALLMAN; Scott E Cruickshank; Eric H Sasso; David Chernoff; Ronald F van Vollenhoven
• Department/s: Clinical Sciences, Helsingborg; Rheumatology; Lund Arthritis Research Group (LARG)
• Publishing year: 2016
• Language: English
• Pages: 000197-000197
• Publication/Series: RMD Open
• Volume: 2
• Issue: 1
• Links: http://www.ncbi.nlm.nih.gov/pubmed/26958364?dopt=Abstract; http://dx.doi.org/10.1136/rmdopen-2015-000197
• Document type: Journal article
• Publisher: BMJ Publishing Group
• Topic: Rheumatology and Autoimmunity
• Status: Published
• Research group: Lund Arthritis Research Group (LARG)
• ISBN/ISSN/Other: ISSN: 2056-5933